Effect of DOACs vs LMWHs
| Composite outcome . | Relative effect (95% CI) . | Proportion of events, % . |
|---|---|---|
| Including asymptomatic events | 0.88 (0.76-1.01) | |
| Asymptomatic proximal DVT | 0.84 (0.70-1.01) | 64.1 |
| Symptomatic proximal or distal DVT | 0.62 (0.36-1.05) | 8.5 |
| PE | 0.67 (0.41-1.09) | 6.6 |
| Death due to DVT | 0.70 (0.45-1.08) | 8.3 |
| Major bleeding | 1.99 (1.08-3.65) | 12.4 |
| Based only on symptomatic events | 1.04 (0.67-1.60) | |
| Symptomatic DVT | 0.62 (0.36-1.05) | 23.8 |
| PE | 0.67 (0.41-1.09) | 31.0 |
| Major bleeding | 1.99 (1.08-3.65) | 45.1 |
| Composite outcome . | Relative effect (95% CI) . | Proportion of events, % . |
|---|---|---|
| Including asymptomatic events | 0.88 (0.76-1.01) | |
| Asymptomatic proximal DVT | 0.84 (0.70-1.01) | 64.1 |
| Symptomatic proximal or distal DVT | 0.62 (0.36-1.05) | 8.5 |
| PE | 0.67 (0.41-1.09) | 6.6 |
| Death due to DVT | 0.70 (0.45-1.08) | 8.3 |
| Major bleeding | 1.99 (1.08-3.65) | 12.4 |
| Based only on symptomatic events | 1.04 (0.67-1.60) | |
| Symptomatic DVT | 0.62 (0.36-1.05) | 23.8 |
| PE | 0.67 (0.41-1.09) | 31.0 |
| Major bleeding | 1.99 (1.08-3.65) | 45.1 |